Schlegel S - Search Results

1

Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.

Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K. Schlegel S, et al. Psychopharmacology (Berl). 1996 Apr;124(3):285-7. doi: 10.1007/BF02246671. Psychopharmacology (Berl). 1996. PMID: 8740053

2

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.

Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O. Schlegel S, et al. Eur Arch Psychiatry Clin Neurosci. 1994;244(1):49-51. doi: 10.1007/BF02279812. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 7918702

3

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.

Schlösser R, Schlegel S, Hiemke C, Nickel O, Bockisch A, Rao ML, Hahn K. Schlösser R, et al. Among authors: schlegel s. Psychiatry Res. 1997 Sep 29;75(2):103-14. doi: 10.1016/s0925-4927(97)00044-9. Psychiatry Res. 1997. PMID: 9351492

4

Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.

Gründer G, Müller MJ, Andreas J, Heydari N, Wetzel H, Schlösser R, Schlegel S, Nickel O, Eissner D, Benkert O. Gründer G, et al. Among authors: schlegel s. Psychopharmacology (Berl). 1999 Sep 1;146(1):81-6. doi: 10.1007/s002130051091. Psychopharmacology (Berl). 1999. PMID: 10485968

5

D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.

Schlösser R, Schlegel S. Schlösser R, et al. Among authors: schlegel s. J Neural Transm Gen Sect. 1995;99(1-3):173-85. doi: 10.1007/BF01271477. J Neural Transm Gen Sect. 1995. PMID: 8579803 Review.

6

Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.

Anghelescu I, Szegedi A, Schlegel S, Weigmann H, Hiemke C, Wetzel H. Anghelescu I, et al. Among authors: schlegel s. Eur Neuropsychopharmacol. 1998 Dec;8(4):315-20. doi: 10.1016/s0924-977x(97)00093-x. Eur Neuropsychopharmacol. 1998. PMID: 9928923 Clinical Trial.

7

Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.

Szegedi A, Anghelescu I, Wiesner J, Schlegel S, Weigmann H, Härtter S, Hiemke C, Wetzel H. Szegedi A, et al. Among authors: schlegel s. Pharmacopsychiatry. 1999 Jul;32(4):148-53. doi: 10.1055/s-2007-979221. Pharmacopsychiatry. 1999. PMID: 10505485 Clinical Trial.

8

Regional cerebral blood flow in depression: associations with psychopathology.

Schlegel S, Aldenhoff JB, Eissner D, Lindner P, Nickel O. Schlegel S, et al. J Affect Disord. 1989 Nov-Dec;17(3):211-8. doi: 10.1016/0165-0327(89)90002-5. J Affect Disord. 1989. PMID: 2529289

9

Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes.

Hiemke C, Stolp M, Reuss S, Wevers A, Reinhardt S, Maelicke A, Schlegel S, Schröder H. Hiemke C, et al. Among authors: schlegel s. Neurosci Lett. 1996 Aug 23;214(2-3):171-4. doi: 10.1016/0304-3940(96)12908-6. Neurosci Lett. 1996. PMID: 8878111

10

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.

Wetzel H, Szegedi A, Hain C, Wiesner J, Schlegel S, Benkert O. Wetzel H, et al. Among authors: schlegel s. Psychopharmacology (Berl). 1995 May;119(2):231-8. doi: 10.1007/BF02246165. Psychopharmacology (Berl). 1995. PMID: 7659771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters